GKB Ophthalmics

Market Cap: Micro Cap
Industry: FMCG
ISIN: INE265D01015
NSEID: GKB
BSEID: 533212

INR

65.68

2.68 (4.25%)

BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 663

{
  "main_header": {
    "sid": 360373,
    "name": "GKB Ophthalmics",
    "stock_name": "GKB Ophthalmics",
    "full_name": "GKB Ophthalmics Ltd",
    "name_url": "stocks-analysis/gkb-ophthalmics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "65.68",
    "chg": 2.68,
    "chgp": "4.25%",
    "dir": 1,
    "prev_price": "63.00",
    "mcapval": "34.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533212,
    "symbol": "GKB",
    "ind_name": "FMCG",
    "ind_code": 31,
    "isin": "INE265D01015",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "00:19 AM",
    "bse_nse_vol": "663 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GKB Ophthalmics Faces Financial Struggles Amid Significant Stock Volatility and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-hits-52-week-low-amid-significant-stock-decline-and-operating-losses-1647443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GKBOphthalmics_priceRelatedfactors_846700.png",
        "date": "2025-03-28 15:38:05",
        "description": "GKB Ophthalmics has faced notable volatility, hitting a 52-week low and underperforming its sector significantly. The company is grappling with operating losses, a negative EBIT to interest ratio, and low return on equity. Over the past year, it has declined sharply, contrasting with broader market gains."
      },
      {
        "title": "GKB Ophthalmics Faces Significant Challenges Amidst Ongoing Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-hits-52-week-low-amid-ongoing-stock-decline-and-financial-concerns-1621873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GKBOphthalmics_priceRelatedfactors_817175.png",
        "date": "2025-03-27 09:49:23",
        "description": "GKB Ophthalmics has faced notable volatility, reaching a new 52-week low and underperforming its sector. The company has seen a significant decline over the past year, with weak financial metrics, including an operating loss and low return on equity, indicating ongoing challenges in profitability and debt servicing."
      },
      {
        "title": "GKB Ophthalmics Faces Significant Challenges Amidst Continued Stock Decline and Poor Financial Health",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-hits-52-week-low-at-rs-68-15-amid-ongoing-decline-1621879",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GKBOphthalmics_priceRelatedfactors_817172.png",
        "date": "2025-03-27 09:49:21",
        "description": "GKB Ophthalmics has faced notable volatility, reaching a new 52-week low and underperforming its sector. The company has reported significant declines over the past year, with operating losses and a concerning EBIT to interest ratio. Technical indicators also suggest a bearish trend in its stock performance."
      },
      {
        "title": "GKB Ophthalmics Faces Significant Volatility Amidst Declining Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-hits-52-week-low-amid-continued-stock-decline-and-weak-financials-1606232",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GKBOphthalmics_priceRelatedfactors_807595.png",
        "date": "2025-03-26 13:36:35",
        "description": "GKB Ophthalmics has faced significant volatility, hitting a new 52-week low and underperforming its sector. The stock has declined over four consecutive days and is trading below key moving averages. Financially, the company shows operating losses and a low return on equity, indicating challenges in profitability."
      },
      {
        "title": "GKB Ophthalmics Faces Challenges Amid Significant Stock Volatility and Poor Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-hits-52-week-low-amid-ongoing-stock-decline-and-operational-challenges-1583436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GKBOphthalmics_priceRelatedfactors_785053.png",
        "date": "2025-03-25 13:05:36",
        "description": "GKB Ophthalmics has reached a new 52-week low, reflecting significant volatility and underperformance in the FMCG sector. The company is trading below key moving averages and has reported operating losses, a low return on equity, and negative profit margins, indicating ongoing financial challenges and a deteriorating outlook."
      },
      {
        "title": "GKB Ophthalmics Faces Significant Market Challenges Amid Sustained Downward Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-hits-new-52-week-low-at-rs-73-amid-declining-performance-1177932",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/GKBOphthalmics_priceRelatedfactors_563119.png",
        "date": "2025-03-03 14:20:35",
        "description": "GKB Ophthalmics has faced significant volatility, hitting a new 52-week low of Rs. 73 and underperforming its sector. The stock has reversed recent gains, trading below all major moving averages and experiencing a year-over-year decline, contrasting with the modest increase in the Sensex."
      },
      {
        "title": "GKB Ophthalmics Reports Stable Financial Results Amid Score Adjustment in February 2025",
        "link": "https://www.marketsmojo.com/news/result-analysis/gkb-ophthalmics-reports-flat-financial-performance-for-december-2024-score-drops-to-4-1003569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/GKBOphthalmics_quaterlyResult_437102.png",
        "date": "2025-02-13 22:48:32",
        "description": "GKB Ophthalmics has announced its financial results for the quarter ending December 2024, revealing stable performance. However, the company's stock evaluation has seen a significant shift, indicating a revised assessment of its financial standing, which may be relevant for stakeholders monitoring its industry position."
      }
    ],
    "total": 16,
    "sid": "360373",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/gkb-ophthalmics-360373"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.",
      "datetime": "02-Apr-2025",
      "details": "Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulation 2011 for the financial year ended on March 31 2025 received from Mr. Krishna Gopal Gupta (K.G. Gupta) Promoter of the Company on behalf of Promoter and Promoter group of the Company. We request you to please take the above information on record.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation 2015- Completion Of Tenure Of Independent Director And Re- Constitution Of Committees Of The Board.",
      "datetime": "31-Mar-2025",
      "details": "In compliance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company by way of resolution passed by circulation today i.e. March 31 2025 has inter-alia considered wand approved the following: 1. The Board members took note of the retirement of Mrs. Shashi Katreddi (DIN: 07139250) as an Independent Director Non- Executive Director of the Company with effect from close of business hours on March 31 2025 due to the completion of her tenure. 2.Further the Board of Directors of the Company has approved the re-constitution of the Audit Committee Nomination and Remuneration Committee and Stakeholders Relationship Committee with effect from April 01 2025. We request you to kindly take the above information on record.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
      "datetime": "31-Mar-2025",
      "details": "Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations 2015 (PIT Regulations 2015) intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF) has purchased 210 equity shares aggregating of Rs. 17705.36 /- from 25.02.2025 to 25.02.2025 on market which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation 2015. However as a good Corporate Governance measure the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation 2015 is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta & Sons-HUF . Please acknowledge and take the same on record.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10",
          "dt": "2010-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

GKB Ophthalmics Faces Financial Struggles Amid Significant Stock Volatility and Decline

2025-03-28 15:38:05

GKB Ophthalmics has faced notable volatility, hitting a 52-week low and underperforming its sector significantly. The company is grappling with operating losses, a negative EBIT to interest ratio, and low return on equity. Over the past year, it has declined sharply, contrasting with broader market gains.

GKB Ophthalmics Faces Significant Challenges Amidst Ongoing Market Volatility

2025-03-27 09:49:23

GKB Ophthalmics has faced notable volatility, reaching a new 52-week low and underperforming its sector. The company has seen a significant decline over the past year, with weak financial metrics, including an operating loss and low return on equity, indicating ongoing challenges in profitability and debt servicing.

GKB Ophthalmics Faces Significant Challenges Amidst Continued Stock Decline and Poor Financial Health

2025-03-27 09:49:21

GKB Ophthalmics has faced notable volatility, reaching a new 52-week low and underperforming its sector. The company has reported significant declines over the past year, with operating losses and a concerning EBIT to interest ratio. Technical indicators also suggest a bearish trend in its stock performance.

GKB Ophthalmics Faces Significant Volatility Amidst Declining Financial Performance

2025-03-26 13:36:35

GKB Ophthalmics has faced significant volatility, hitting a new 52-week low and underperforming its sector. The stock has declined over four consecutive days and is trading below key moving averages. Financially, the company shows operating losses and a low return on equity, indicating challenges in profitability.

GKB Ophthalmics Faces Challenges Amid Significant Stock Volatility and Poor Financial Performance

2025-03-25 13:05:36

GKB Ophthalmics has reached a new 52-week low, reflecting significant volatility and underperformance in the FMCG sector. The company is trading below key moving averages and has reported operating losses, a low return on equity, and negative profit margins, indicating ongoing financial challenges and a deteriorating outlook.

GKB Ophthalmics Faces Significant Market Challenges Amid Sustained Downward Trend

2025-03-03 14:20:35

GKB Ophthalmics has faced significant volatility, hitting a new 52-week low of Rs. 73 and underperforming its sector. The stock has reversed recent gains, trading below all major moving averages and experiencing a year-over-year decline, contrasting with the modest increase in the Sensex.

GKB Ophthalmics Reports Stable Financial Results Amid Score Adjustment in February 2025

2025-02-13 22:48:32

GKB Ophthalmics has announced its financial results for the quarter ending December 2024, revealing stable performance. However, the company's stock evaluation has seen a significant shift, indicating a revised assessment of its financial standing, which may be relevant for stakeholders monitoring its industry position.

View All News

Announcement

Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.

02-Apr-2025 | Source : BSE

Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulation 2011 for the financial year ended on March 31 2025 received from Mr. Krishna Gopal Gupta (K.G. Gupta) Promoter of the Company on behalf of Promoter and Promoter group of the Company. We request you to please take the above information on record.

Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation 2015- Completion Of Tenure Of Independent Director And Re- Constitution Of Committees Of The Board.

31-Mar-2025 | Source : BSE

In compliance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company by way of resolution passed by circulation today i.e. March 31 2025 has inter-alia considered wand approved the following: 1. The Board members took note of the retirement of Mrs. Shashi Katreddi (DIN: 07139250) as an Independent Director Non- Executive Director of the Company with effect from close of business hours on March 31 2025 due to the completion of her tenure. 2.Further the Board of Directors of the Company has approved the re-constitution of the Audit Committee Nomination and Remuneration Committee and Stakeholders Relationship Committee with effect from April 01 2025. We request you to kindly take the above information on record.

Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015

31-Mar-2025 | Source : BSE

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations 2015 (PIT Regulations 2015) intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF) has purchased 210 equity shares aggregating of Rs. 17705.36 /- from 25.02.2025 to 25.02.2025 on market which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation 2015. However as a good Corporate Governance measure the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation 2015 is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta & Sons-HUF . Please acknowledge and take the same on record.